Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 556

1.

Successful Treatment of End-stage Renal Disease in a Patient With Chronic Myeloid Leukemia by Kidney Transplantation and Tyrosine Kinase Inhibitors: A Case Report.

Shinoda K, Morita S, Tamaki S, Takahashi R, Kitaoka S, Asanuma H, Yoshida T, Okayama M, Kasahara H, Okamoto S, Oya M.

Transplant Proc. 2020 Feb 3. pii: S0041-1345(19)31076-0. doi: 10.1016/j.transproceed.2019.10.035. [Epub ahead of print]

PMID:
32029318
2.

SNA/RNA hybridization promoted with 2,6-diaminopurine and 2-thiouracil, which suppress self-hybridization of SNA.

Kamiya Y, Sato F, Murayama K, Kodama A, Uchiyama S, Asanuma H.

Chem Asian J. 2020 Feb 5. doi: 10.1002/asia.201901728. [Epub ahead of print]

PMID:
32020729
3.

Human Immune Responses Elicited by an Intranasal Inactivated H5 Influenza Vaccine.

Ainai A, van Riet E, Ito R, Ikeda K, Senchi K, Suzuki T, Tamura SI, Asanuma H, Odagiri T, Tashiro M, Kurata T, Multihartina P, Setiawaty V, Andriana Pangesti KN, Hasegawa H.

Microbiol Immunol. 2020 Jan 20. doi: 10.1111/1348-0421.12775. [Epub ahead of print]

PMID:
31957054
4.

Peptide vaccinations elicited strong immune responses that were reboosted by anti-PD1 therapy in a patient with myxofibrosarcoma.

Tsukahara T, Watanabe K, Murata K, Takahashi A, Mizushima E, Shibayama Y, Kameshima H, Hatae R, Ohno Y, Kawahara R, Murai A, Nakatsugawa M, Kubo T, Kanaseki T, Hirohashi Y, Terui T, Asanuma H, Hasegawa T, Sato N, Torigoe T.

Cancer Immunol Immunother. 2020 Feb;69(2):189-197. doi: 10.1007/s00262-019-02455-0. Epub 2019 Dec 18.

PMID:
31853575
5.

Factors affecting renal function preservation among patients not achieving trifecta after laparoscopic partial nephrectomy for clinical T1a renal masses.

Takeda T, Komatsuda A, Yanai Y, Tanaka N, Matsumoto K, Morita S, Kosaka T, Mizuno R, Shinojima T, Asanuma H, Oya M.

Asian J Endosc Surg. 2019 Dec 9. doi: 10.1111/ases.12776. [Epub ahead of print]

PMID:
31814326
6.

Difference in the prevalence of subclinical left ventricular impairment among left ventricular geometric pattern in a community-based population.

Hasegawa T, Asakura M, Asanuma H, Amaki M, Takahama H, Sugano Y, Kanzaki H, Yasuda S, Anzai T, Izumi C, Kitakaze M.

J Cardiol. 2020 Apr;75(4):439-446. doi: 10.1016/j.jjcc.2019.09.007. Epub 2019 Dec 6.

PMID:
31813675
7.

Vibration Viscosity Sensor for Engine Oil Monitoring Using Metal Matrix Piezoelectric Composite.

Yanaseko T, Sato H, Kuboki I, Mossi K, Asanuma H.

Materials (Basel). 2019 Oct 18;12(20). pii: E3415. doi: 10.3390/ma12203415.

8.

The efficacy of the TachoSil binding suturing technique in laparoscopic partial nephrectomy to prevent the development of pseudoaneurysm.

Shigeta K, Matsumoto K, Abe T, Komatsuda A, Takeda T, Mizuno R, Kikuchi E, Asanuma H, Arita Y, Akita H, Jinzaki M, Miyajima A, Oya M.

Asian J Surg. 2019 Oct 16. pii: S1015-9584(19)30793-6. doi: 10.1016/j.asjsur.2019.09.002. [Epub ahead of print]

9.

Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy.

Matsumoto K, Niwa N, Hagiwara M, Kosaka T, Tanaka N, Takeda T, Morita S, Mizuno R, Shinojima T, Hara S, Asanuma H, Oya M.

World J Urol. 2019 Sep 26. doi: 10.1007/s00345-019-02970-w. [Epub ahead of print]

PMID:
31559475
10.

A Quencher-Free Linear Probe from Serinol Nucleic Acid with a Fluorescent Uracil Analogue.

Murayama K, Asanuma H.

Chembiochem. 2020 Jan 15;21(1-2):120-128. doi: 10.1002/cbic.201900498. Epub 2019 Nov 21.

PMID:
31549777
11.

Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.

Nakamura K, Harada Y, Takahashi H, Trusheim H, Bernhard R, Hamamoto I, Hirata-Saito A, Ogane T, Mizuta K, Konomi N, Konomi Y, Asanuma H, Odagiri T, Tashiro M, Yamamoto N.

Vaccine. 2019 Oct 8;37(43):6526-6534. doi: 10.1016/j.vaccine.2019.08.064. Epub 2019 Sep 6.

12.

Successful perinatal management of a dichorionic diamniotic twin pregnancy in an anaemic kidney transplant patient treated with Darbepoetin alfa: a case report.

Tamaki S, Shinoda K, Matsumoto T, Morita S, Asanuma H, Yoshida T, Oya M.

J Obstet Gynaecol. 2019 Sep 3:1-3. doi: 10.1080/01443615.2019.1636776. [Epub ahead of print] No abstract available.

PMID:
31478423
13.

Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodies.

Adachi Y, Tonouchi K, Nithichanon A, Kuraoka M, Watanabe A, Shinnakasu R, Asanuma H, Ainai A, Ohmi Y, Yamamoto T, Ishii KJ, Hasegawa H, Takeyama H, Lertmemongkolchai G, Kurosaki T, Ato M, Kelsoe G, Takahashi Y.

Nat Commun. 2019 Aug 28;10(1):3883. doi: 10.1038/s41467-019-11821-6.

14.

CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses.

Tateishi K, Fujihashi K, Yamamoto N, Hasegawa H, Ainai A, Sato K, Iho S, Yamamoto S, Maeyama JI, Odagiri T, Asanuma H.

Vaccine. 2019 Aug 23;37(36):5382-5389. doi: 10.1016/j.vaccine.2019.07.032. Epub 2019 Jul 22.

PMID:
31345642
15.

Endogenously released adenosine causes pulmonary vasodilation during the acute phase of pulmonary embolization in dogs.

Takahama H, Asanuma H, Tsukamoto O, Ito S, Kitakaze M.

Int J Cardiol Heart Vasc. 2019 Jul 10;24:100396. doi: 10.1016/j.ijcha.2019.100396. eCollection 2019 Sep.

16.

Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA-A24-positive pancreatic adenocarcinoma.

Shima H, Tsurita G, Wada S, Hirohashi Y, Yasui H, Hayashi H, Miyakoshi T, Watanabe K, Murai A, Asanuma H, Tokita S, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Nakae Y, Sugita O, Ito YM, Ota Y, Kimura Y, Kutomi G, Hirata K, Mizuguchi T, Imai K, Takemasa I, Sato N, Torigoe T.

Cancer Sci. 2019 Aug;110(8):2378-2385. doi: 10.1111/cas.14106. Epub 2019 Jul 23.

17.

Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy series.

Kubo T, Tsurita G, Hirohashi Y, Yasui H, Ota Y, Watanabe K, Murai A, Matsuo K, Asanuma H, Shima H, Wada S, Nakatsugawa M, Kanaseki T, Tsukahara T, Mizuguchi T, Hirata K, Takemasa I, Imai K, Sato N, Torigoe T.

Cancer Sci. 2019 Aug;110(8):2386-2395. doi: 10.1111/cas.14099. Epub 2019 Jul 11.

18.

Cardiovascular Outcomes in Patients With Previous Myocardial Infarction and Mild Diabetes Mellitus Following Treatment With Pioglitazone: Reports of a Randomised Trial From The Japan Working Group for the Assessment Whether Pioglitazone Protects DM Patients Against Re-Infarction (PPAR Study).

Asakura M, Kim J, Asanuma H, Nakama Y, Tsukahara K, Higashino Y, Ishikawa T, Koba S, Tsujimoto M, Himeno H, Maruyama Y, Ookusa T, Yoda S, Suzuki H, Okubo S, Shimizu M, Hashimoto Y, Satake K, Fujino S, Uzui H, Nagai Y, Kohno T, Mizuno S, Nakahama M, Kanaya H, Murohara T, Fukui K, Takase H, Ohte N, Shiono T, Fukunami M, Endo T, Sawada R, Fujii K, Takeuchi M, Ikeda S, Mizuno K, Uematsu M, Matsubara T, Yano S, Takahashi J, Ueda K, Kinoshita Y, Tamita K, Hayashi H, Hamasaki T, Kitakaze M; PPAR investigators.

EClinicalMedicine. 2018 Oct 22;4-5:10-24. doi: 10.1016/j.eclinm.2018.09.006. eCollection 2018 Oct-Nov.

19.

8-Pyrenylvinyl Adenine Controls Reversible Duplex Formation between Serinol Nucleic Acid and RNA by [2 + 2] Photocycloaddition.

Murayama K, Yamano Y, Asanuma H.

J Am Chem Soc. 2019 Jun 19;141(24):9485-9489. doi: 10.1021/jacs.9b03267. Epub 2019 May 23.

PMID:
31117655
20.

Selective binding of nucleosides to gapped DNA duplex revealed by orientation and distance dependence of FRET.

Kashida H, Kokubo Y, Makino K, Asanuma H.

Org Biomol Chem. 2019 Jul 17;17(28):6786-6789. doi: 10.1039/c9ob00946a.

PMID:
31114836
21.

Preserved Kidney Volume, Body Mass Index, and Age Are Significant Preoperative Factors for Predicting Estimated Glomerular Filtration Rate in Living Kidney Donors at 1 Year After Donation.

Shinoda K, Morita S, Akita H, Washizuka F, Tamaki S, Takahashi R, Oguchi H, Sakurabayashi K, Mizutani T, Takahashi Y, Hyodo Y, Itabashi Y, Muramatsu M, Kawamura T, Asanuma H, Kikuchi E, Jinzaki M, Shiraga N, Nakagawa K, Oya M, Shishido S, Sakai K.

Transplant Proc. 2019 Jun;51(5):1306-1310. doi: 10.1016/j.transproceed.2019.01.142. Epub 2019 May 7.

PMID:
31076152
22.

Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients.

Takamatsu K, Mizuno R, Tanaka N, Takeda T, Morita S, Matsumoto K, Kosaka T, Shinojima T, Kikuchi E, Asanuma H, Oyama M, Mikami S, Oya M.

Int J Clin Oncol. 2019 Sep;24(9):1069-1074. doi: 10.1007/s10147-019-01459-1. Epub 2019 May 7.

PMID:
31065836
23.

The Use of Serinol Nucleic Acids as Ultrasensitive Molecular Beacons.

Murayama K, Kashida H, Asanuma H.

Methods Mol Biol. 2019;1973:261-279. doi: 10.1007/978-1-4939-9216-4_17.

PMID:
31016708
24.

The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy.

Takamatsu K, Matsumoto K, Shojo K, Tanaka N, Takeda T, Morita S, Kosaka T, Mizuno R, Shinojima T, Kikuchi E, Asanuma H, Oya M.

Urol Oncol. 2019 Sep;37(9):575.e19-575.e25. doi: 10.1016/j.urolonc.2019.03.012. Epub 2019 Apr 6.

PMID:
30967332
25.

Small intestinal perforation due to a huge gastrointestinal stromal tumor in a kidney transplant recipient: a case report and literature review.

Takahashi R, Shinoda K, Ishida T, Hamamoto Y, Morita S, Akita H, Kitaoka S, Tamaki S, Asanuma H, Yoshida T, Jinzaki M, Kameyama K, Oya M.

BMC Nephrol. 2019 Apr 3;20(1):120. doi: 10.1186/s12882-019-1310-5.

26.

AST-120, an Adsorbent of Uremic Toxins, Improves the Pathophysiology of Heart Failure in Conscious Dogs.

Asanuma H, Chung H, Ito S, Min KD, Ihara M, Takahama H, Funayama M, Imazu M, Fukuda H, Ogai A, Asano Y, Minamino T, Takashima S, Morita T, Sugimachi M, Asakura M, Kitakaze M.

Cardiovasc Drugs Ther. 2019 Jun;33(3):277-286. doi: 10.1007/s10557-019-06875-z.

PMID:
30903544
27.

Orthogonally Photocontrolled Non-Autonomous DNA Walker.

Škugor M, Valero J, Murayama K, Centola M, Asanuma H, Famulok M.

Angew Chem Int Ed Engl. 2019 May 20;58(21):6948-6951. doi: 10.1002/anie.201901272. Epub 2019 Apr 12.

PMID:
30897257
28.

A dipeptidyl peptidase-IV inhibitor improves diastolic dysfunction in Dahl salt-sensitive rats.

Nakajima Y, Ito S, Asakura M, Min KD, Fu HY, Imazu M, Hitsumoto T, Takahama H, Shindo K, Fukuda H, Yamazaki S, Asanuma H, Kitakaze M.

J Mol Cell Cardiol. 2019 Apr;129:257-265. doi: 10.1016/j.yjmcc.2019.03.009. Epub 2019 Mar 14.

PMID:
30880253
29.

Isothermal double-cycle catalytic system using DNAzyme and RNase H for the highly selective one-pot detection of oligonucleotides.

An R, Kawai H, Asanuma H, Komiyama M, Liang X.

Analyst. 2019 Apr 8;144(8):2773-2779. doi: 10.1039/c8an02520g.

PMID:
30869659
30.

Mutant KCNJ3 and KCNJ5 Potassium Channels as Novel Molecular Targets in Bradyarrhythmias and Atrial Fibrillation.

Yamada N, Asano Y, Fujita M, Yamazaki S, Inanobe A, Matsuura N, Kobayashi H, Ohno S, Ebana Y, Tsukamoto O, Ishino S, Takuwa A, Kioka H, Yamashita T, Hashimoto N, Zankov DP, Shimizu A, Asakura M, Asanuma H, Kato H, Nishida Y, Miyashita Y, Shinomiya H, Naiki N, Hayashi K, Makiyama T, Ogita H, Miura K, Ueshima H, Komuro I, Yamagishi M, Horie M, Kawakami K, Furukawa T, Koizumi A, Kurachi Y, Sakata Y, Minamino T, Kitakaze M, Takashima S.

Circulation. 2019 Apr 30;139(18):2157-2169. doi: 10.1161/CIRCULATIONAHA.118.036761.

PMID:
30764634
31.

Pre-donation BMI and preserved kidney volume can predict the cohort with unfavorable renal functional compensation at 1-year after kidney donation.

Shinoda K, Morita S, Akita H, Tamaki S, Takahashi R, Kono H, Asanuma H, Kikuchi E, Jinzaki M, Nakagawa K, Oya M.

BMC Nephrol. 2019 Feb 8;20(1):46. doi: 10.1186/s12882-019-1242-0.

32.

In-stem molecular beacon targeted to a 5'-region of tRNA inclusive of the D arm that detects mature tRNA with high sensitivity.

Miyoshi Y, Ohtsuki T, Kashida H, Asanuma H, Watanabe K.

PLoS One. 2019 Jan 29;14(1):e0211505. doi: 10.1371/journal.pone.0211505. eCollection 2019.

33.

Editorial Comment.

Asanuma H.

J Urol. 2019 Feb;201(2):385. doi: 10.1097/01.JU.0000553003.73595.8e. No abstract available.

PMID:
30634373
34.

Efficient protection of mice from influenza A/H1N1pdm09 virus challenge infection via high avidity serum antibodies induced by booster immunizations with inactivated whole virus vaccine.

Sato K, Takahashi Y, Adachi Y, Asanuma H, Ato M, Tashiro M, Itamura S.

Heliyon. 2019 Jan 3;5(1):e01113. doi: 10.1016/j.heliyon.2018.e01113. eCollection 2019 Jan.

35.

Photo-regulatable DNA isothermal amplification by template-mediated ligation.

Cheng B, Kashida H, Shimada N, Maruyama A, Asanuma H.

Chem Commun (Camb). 2019 Jan 25;55(8):1080-1083. doi: 10.1039/c8cc09218d. Epub 2019 Jan 8.

PMID:
30617360
36.

Rare association of the anterior and posterior urethral valves.

Murakami T, Asanuma H, Shigeta K, Ezaki T, Oya M.

Pediatr Int. 2018 Dec;60(12):1090-1091. doi: 10.1111/ped.13711. No abstract available.

PMID:
30585406
37.

Is transperitoneal laparoscopic radical nephrectomy suitable for patients with a history of abdominal surgery?

Yanai Y, Takeda T, Miyajima A, Matsumoto K, Hagiwara M, Mizuno R, Kikuchi E, Asanuma H, Oya M.

Asian J Endosc Surg. 2019 Oct;12(4):429-433. doi: 10.1111/ases.12673. Epub 2018 Dec 2.

PMID:
30506839
38.

Anti-HB-EGF Antibody-Mediated Delivery of siRNA to Atherosclerotic Lesions in Mice.

Tsuchida S, Matsuzaki T, Yamato M, Okuda K, Fu HY, Araki R, Sanada S, Asanuma H, Asano Y, Asakura M, Hao H, Takashima S, Kitakaze M, Sakata Y, Mekada E, Minamino T.

Int Heart J. 2018 Nov 28;59(6):1425-1431. doi: 10.1536/ihj.17-644. Epub 2018 Nov 5.

39.

Detection of specific gene rearrangements by fluorescence in situ hybridization in 16 cases of clear cell sarcoma of soft tissue and 6 cases of clear cell sarcoma-like gastrointestinal tumor.

Segawa K, Sugita S, Aoyama T, Kubo T, Asanuma H, Sugawara T, Ito Y, Tsujiwaki M, Fujita H, Emori M, Hasegawa T.

Diagn Pathol. 2018 Sep 15;13(1):73. doi: 10.1186/s13000-018-0752-6.

40.

Development of screening method for intranasal influenza vaccine and adjuvant safety in preclinical study.

Hiradate Y, Sasaki E, Momose H, Asanuma H, Furuhata K, Takai M, Aoshi T, Yamada H, Ishii KJ, Tanemura K, Mizukami T, Hamaguchi I.

Biologicals. 2018 Sep;55:43-52. doi: 10.1016/j.biologicals.2018.07.001. Epub 2018 Jul 14.

PMID:
30017557
41.

Bifacial Nucleobases for Hexaplex Formation in Aqueous Solution.

Kashida H, Hattori Y, Tazoe K, Inoue T, Nishikawa K, Ishii K, Uchiyama S, Yamashita H, Abe M, Kamiya Y, Asanuma H.

J Am Chem Soc. 2018 Jul 11;140(27):8456-8462. doi: 10.1021/jacs.8b02807. Epub 2018 Jun 21.

PMID:
29886741
42.

Establishment of the optimal follow-up schedule after radical prostatectomy.

Matsumoto K, Niwa N, Hattori S, Takeda T, Morita S, Kosaka T, Mizuno R, Shinojima T, Kikuchi E, Asanuma H, Oya M.

Urol Oncol. 2018 Jul;36(7):341.e9-341.e14. doi: 10.1016/j.urolonc.2018.04.003. Epub 2018 May 3.

PMID:
29730065
43.

Development of Visible-Light-Responsive RNA Scissors Based on a 10-23 DNAzyme.

Kamiya Y, Arimura Y, Ooi H, Kato K, Liang XG, Asanuma H.

Chembiochem. 2018 Jun 18;19(12):1305-1311. doi: 10.1002/cbic.201800020. Epub 2018 May 30.

PMID:
29682882
44.

Retrocaval Ureter Manifested after Ureteral Reimplantation for Ipsilateral Vesicoureteral Reflux: A Case Report.

Katsui M, Asanuma H, Fukumoto K, Mizuno R, Oya M.

Urol J. 2018 Nov 17;15(6):397-399. doi: 10.22037/uj.v0i0.4103.

45.

Prognostic Value of Baseline Serum C-Reactive Protein Level in Intermediate-Risk Group Patients With Metastatic Renal-Cell Carcinoma Treated by First-Line Vascular Endothelial Growth Factor-Targeted Therapy.

Takamatsu K, Mizuno R, Omura M, Morita S, Matsumoto K, Shinoda K, Kosaka T, Takeda T, Shinojima T, Kikuchi E, Asanuma H, Oyama M, Mikami S, Oya M.

Clin Genitourin Cancer. 2018 Aug;16(4):e927-e933. doi: 10.1016/j.clgc.2018.03.012. Epub 2018 Mar 27.

PMID:
29678472
46.

High-dose chemotherapy without whole lung radiation for refractory pulmonary metastases in an infant with stage IV favorable histology Wilms tumor.

Shima H, Yamada Y, Asanuma H, Shimada H.

Pediatr Blood Cancer. 2018 Aug;65(8):e27078. doi: 10.1002/pbc.27078. Epub 2018 Apr 20. No abstract available.

PMID:
29676506
47.

Cutting Edge Science and Medicine of Adenosine in Patients With Heart Failure.

Asanuma H, Kitakaze M.

Circ J. 2018 Apr 25;82(5):1247-1248. doi: 10.1253/circj.CJ-18-0327. Epub 2018 Apr 4. No abstract available.

48.

Incidence and timing of inadvertent nephrostomy catheter displacement in patients with ureteral obstruction
.

Niwa N, Matsumoto K, Kikuchi E, Yazawa S, Takeda T, Morita S, Kosaka T, Shinoda K, Mizuno R, Shinojima T, Asanuma H, Oya M.

Clin Nephrol. 2018 Aug;90(2):112-116. doi: 10.5414/CN109294.

PMID:
29578400
49.

The impact of creating mathematical formula to predict cardiovascular events in patients with heart failure.

Sakamoto M, Fukuda H, Kim J, Ide T, Kinugawa S, Fukushima A, Tsutsui H, Ishii A, Ito S, Asanuma H, Asakura M, Washio T, Kitakaze M.

Sci Rep. 2018 Mar 5;8(1):3986. doi: 10.1038/s41598-018-22347-0.

50.

Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools.

Sasaki E, Momose H, Hiradate Y, Furuhata K, Takai M, Asanuma H, Ishii KJ, Mizukami T, Hamaguchi I.

PLoS One. 2018 Feb 6;13(2):e0191896. doi: 10.1371/journal.pone.0191896. eCollection 2018.

Supplemental Content

Loading ...
Support Center